High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: Results of the QT in Practice (QTIP) study

Critical Care Medicine

Volumn 40, Issue 2, 2012, Pages 394-399

  Pickham, David ^a   Helfenbein, Eric ^b   Shinn, Julie A ^c   Chan, Garrett ^a   Funk, Marjorie ^d   Weinacker, Ann ^c   Liu, Jia Ni ^a   Drew, Barbara J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PHILIPS HEALTHCARE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

acquired; critical care; electrocardiography; long QT; mortality; predictor; prevalence; QT prolongation

Indexed keywords

CARDIAC AGENT; CREATININE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEART ARREST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOTHYROIDISM; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT PROLONGATION; SEX DIFFERENCE; STROKE; TORSADE DES POINTES;

ACADEMIC MEDICAL CENTERS; ADULT; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; CRITICAL CARE; CRITICAL ILLNESS; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LONG QT SYNDROME; MALE; MONITORING, PHYSIOLOGIC; ODDS RATIO; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TORSADES DE POINTES;

EID: 84856142882     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318232db4a     Document Type: Article

References (28)

1. Zipes DP, Camm AJ, Borggrefe M, et al: ACC/ AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A report of the American College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114:e385-e484
2. Drew BJ, Ackerman MJ, Funk M, et al: Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010; 55:934-947
3. Helfenbein ED, Zhou SH, Lindauer JM, et al: An algorithm for continuous real-time QT interval monitoring. J Electrocardiol 2006; 39:S123-S127
4. Gregg R, Babaeizadeh S, Feild DG, et al: Comparison of two automated methods for QT interval measurement. Computers in Cardiology 2007; 34:427-430
5. Pickham D, Helfenbein E, Shinn JA, et al: How many patients need QT interval monitoring in critical care unitš Preliminary report of the QT in Practice study. J Electrocardiol 2010; 43:572-576
6. Litwin JS, Kleiman RB, Gussak I: Acquired (drug-induced) long QT syndrome. In: Electrical Diseases of the Heart Genetics, Mechanisms, Treatment, Prevention. Gussak I, Anzelevitch C (Eds). London, Springer-Verlag, 2008, pp 705-718
7. Molnar J, Zhang F, Weiss J, et al: Diurnal pattern of QTc interval: How long is prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol 1996; 27:76-83
8. Rautaharju PM, Surawicz B, Gettes LS, et al: AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV: The ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology. Circulation 2009; 119:e241-e250
9. Fukui S, Otani N, Katoh H, et al: Female gender as a risk factor for hypokalemia and QT prolongation after subarachnoid hemorrhage. Neurology 2002; 59:134-136
10. Fukui S, Katoh H, Tsuzuki N, et al: Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage. Crit Care 2003; 7:R7-R12
11. Sommargren CE, Zaroff JG, Banki N, et al: Electrocardiographic repolarization abnormalities in subarachnoid hemorrhage. J Electrocardiol 2002; 35:257-262
12. Burch GE, Meyers R, Abildskov JA: A new electrocardiographic pattern observed in cerebrovascular accidents. Circulation 1954; 9:719-723
13. Benoit SR, Mendelsohn AB, Nourjah P, et al: Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 2005; 12:363-368
14. Bakiner O, Ertorer ME, Haydardedeoglu FE, et al: Subclinical hypothyroidism is characterized by increased QT interval dispersion among women. Med Princ Pract 2008; 17: 390-394
15. Fazio S, Biondi B, Lupoli G, et al: Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart. Angiology 1992; 43:287-293
16. Sohaib SM, Papacosta O, Morris RW, et al: Length of the QT interval: Determinants and prognostic implications in a populationbased prospective study of older men. J Electrocardiol 2008; 41:704-710
17. Lehmann MH, Hardy S, Archibald D, et al: Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 1996; 94: 2535-2541
18. Burkett E, Keijzers G, Lind J: The relationship between blood glucose level and QTc duration in the critically ill. Crit Care Resusc 2009; 11:8-13
19. Zhang Y, Han H, Wang J, et al: Impairment of human ether-à-go-go- related gene (HERG) K channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem 2003; 278:10417-10426
20. Hreiche R, Plante I, David LP, et al: Impact of glucose concentration on cardiac ventricular repolarization under I Kr/I Ks blocking agents. J Mol Cell Cardiol 2009; 47:210-220
21. Makkar RR, Fromm BS, Steinman RT, et al: Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270:2590-2597
22. McNally B, Stokes A, Crouch A, et al: CARES: Cardiac Arrest Registry to Enhance Survival. Ann Emerg Med 2009; 54:674-683.e2
23. Freeman BD, Dixon DJ, Coopersmith CM, etal: Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf 2008; 17:971-981
24. Chao CC, Wang TL, Chong CF, et al: Prognostic value of QT parameters in patients with acute hemorrhagic stroke: A prospective evaluation with respect to mortality and post-hospitalization bed confinement. J Chin Med Assoc 2009; 72:124-132
25. Dekker JM, Crow RS, Hannan PJ, et al: Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: The ARIC study. J Am Coll Cardiol 2004; 43:565-571
26. Okin PM, Devereux RB, Howard BV, et al: Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation 2000; 101:61-66
27. Salles GF, Cardoso CR, Muxfeldt ES: Prognostic value of ventricular repolarization prolongation in resistant hypertension: A prospective cohort study. J Hypertens 2009; 27:1094-1101
28. Robbins J, Nelson JC, Rautaharju PM, et al: The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med 2003; 115: 689-694